bioRxivCell BiologyPreprint
Acquisition of cancer stem cell properties during EMT requires cell division
P. den Hollander, S. V. Vasaikar, M. Castaneda, R. Joseph, A. P. Deshmukh, T. Zhao, M. Pietila, C. Fu, W. F. Symmans, R. Soundararajan, S. A. Mani
Abstract
Cancer cells acquire stem cell and mesenchymal properties during epithelial-to-mesenchymal transition (EMT), facilitating metastasis and chemoresistance [1-6]. In this study, we find that mammary epithelial cells quickly develop mesenchymal phenotype in response to EMT-inducing signals; however, acquiring stemness takes several days and always requires a preceding mesenchymal program. In addition, we observe that carcinoma cells, over a period of time, switch their cell division from symmetrical differentiated type to symmetrical self-renewal type. Importantly, epithelial cells can gain mesenchymal properties without undergoing cell division, but cell disivion is vital for these cells to gain stem cell properties during EMT. The EMT-induced stemness signature (SC-sig) is capable of predicting progression-free and overall-survival of breast cancer patients but not the EMT-induced mesenchymal signature (M-sig). Collectively, our findings demonstrate that the use of mesenchymal markers alone is insufficient to identify tumors with metastatic and chemoresistance potential and emphasize that the markers of EMT-induced stem cell program are central for clinical prediction. Most importantly, our data, for the first time, demonstrate that acquisition of stem cell properties during EMT depends on cell division but not the mesenchymal program.
- organism: human
- assay: bulk RNA-seq
- research focus: cancer & tumor microenvironment
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dynamic plasticity within the EMT spectrum, rather than static mesenchymal traits, drives tumor heterogeneity and metastatic progression of breast cancers
M. S. Brown, B. Abdollahi, … D. R. Pattabiraman·bioRxiv·Mar 17, 2021
- A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling
F. Bocci, M. K. Jolly, … J. N. Onuchic·bioRxiv·May 3, 2018
- Maintenance of epithelial traits and resistance to mesenchymal reprogramming promote proliferation in metastatic breast cancer
L. Eichelberger, M. Saini, … C. H. Scheel·bioRxiv·Mar 19, 2020
- Stromal signals dominate gene expression signature scores that aim to describe cancer-intrinsic stemness or mesenchymality characteristics
Julian Kreis, Bogac Aybey, … Eike Staub·bioRxiv·Aug 25, 2023
- Towards understanding cancer stem cell heterogeneity in the tumor microenvironment
F. Bocci, L. Gearhart-Serna, … M. K. Jolly·Proceedings of the National Academy of SciencesPeer-reviewed·Dec 26, 2018
- Multiple distinct metastatic cell states are induced by epithelial-mesenchymal plasticity
Fahda Alsharief, Robert K. Suter, … Gray W. Pearson·bioRxiv·Aug 15, 2025